Public disclosures

Sherman Darren

Company insiders · See Remarks · Director · Orchestra BioMed Holdings, Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-03.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
1

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Sherman Darren

See Remarks · Director · Orchestra BioMed Holdings, Inc.

OBIO

Orchestra BioMed Holdings, Inc.

Sell
Filing details

SEC transaction code S

Common Stock, par value $0.0001 per share ("Common Stock") · Direct ownership · Reported balance after transaction: 1104402 · SEC code covers open-market or private transactions · The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. · The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $5.66 to $5.995. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote. · President and Chief Operating Officer

2026-11-022026-11-03

≈ $86,100.00

15,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement